In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of . India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we wish to inform you that the Unaudited Financial Results (Standalone) of the Company for the Quarter and Half-Year ended September 30, 2018 were approved by the Board of Directors of the Company at its meeting held today.

Pdf Link: Kappac Pharma Ltd. - Submission Of Audited Financial Result For Quarter And Half-Year Ended September 30,2018 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015

Source : BSE - www.bseindia.com

comment COMMENT NOW